TickerFacts.

Avalo Therapeutics, Inc. (AVTX): Weighted Average Diluted Shares

Annual figures by period end, from SEC filings.

13.40M
Year ended 2025-12-31
n/m
3-year compound annual growth
+19.7%
10-year compound annual growth
34.77M2015-12-31: 2.23M2016-12-31: 8.83M2017-12-31: 18.75M2018-12-31: 34.77M2022-12-31: 39.2K2023-12-31: 277.7K2024-12-31: 7.50M2025-12-31: 13.40M13.40M
2015-12-31 Weighted Average Diluted Shares (shares) 2025-12-31
Period endedWeighted Average Diluted SharesChange YoYSource filing
2025-12-3113.40M+78.8%2026-03-23, From 2025-01-01
2024-12-317.50Mn/m2026-03-23, From 2024-01-01
2023-12-31277.7K+608.5%2025-03-20, From 2023-01-01
2022-12-3139.2Kn/a2024-03-29, From 2022-01-01
No annual figure between 2018-12-31 and 2022-12-31.
2018-12-3134.77M+85.4%2019-03-18, From 2018-01-01
2017-12-3118.75M+112.4%2019-03-18, From 2017-01-01
2016-12-318.83M+296.7%2018-04-02, From 2016-01-01
2015-12-312.23Mn/a2018-04-02, From 2015-01-01